CME Group (CME) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter declined from the preceding quarter but rose compared to the same period one year earlier. The trailing twelve-month revenue was higher than the quarterly figure annualized.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter declined from the preceding quarter but rose compared to the same period one year earlier. The trailing twelve-month revenue was higher than the quarterly figure annualized.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.5B
Revenue reported for this quarter.
Quarter-over-quarter
-3.7%
Change from the immediately preceding quarter.
Year-over-year
+6.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$6.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $1.5B | +3.2% |
| Jun 30, 2024 | $1.5B | +12.7% |
| Sep 30, 2024 | $1.6B | +18.4% |
| Dec 31, 2024 | $1.5B | +6.0% |
Revenue performance
The quarter's revenue decreased sequentially, ending a pattern of growth seen in the prior two quarters. This marks the first quarterly decline in the fiscal year.
Quarterly comparison
Compared to the immediately preceding quarter, revenue declined. Relative to the same quarter one year earlier, revenue increased.
What to watch
The shift from sequential growth to decline is a notable change in the revenue trajectory.